The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,804.00
Bid: 1,813.00
Ask: 1,816.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.165%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,804.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Day Statement

21 Sep 2017 07:00

RNS Number : 3636R
Johnson Matthey PLC
21 September 2017
 

Johnson Matthey Capital Markets Day Statement

 

Today, Johnson Matthey will hold a capital markets day in which it will outline its strategy for growth and value creation, at a group level and across its sectors. This growth is underpinned by its leading positions in high margin, technology driven growth markets. The company expects to deliver sustained growth in Clean Air, break out growth in Battery Materials and Health, and above market growth in Efficient Natural Resources. In the medium term, this will generate attractive returns:

· Expanding group ROIC to 20%

· Delivering mid to high single digit EPS CAGR

· And continuing a progressive dividend policy

 

Overall our Clean Air business will deliver growth in the next ten years. It is expected to achieve strong single digit sales growth in the next two to three years from share gains already achieved in Europe light duty and from upcoming tighter legislation. In subsequent years, sales growth is expected to moderate as expansion in Asia, together with maintaining JM's strong position in heavy duty in North America, is partially offset by the move away from light duty diesel engines in Europe and by the increasing penetration globally of battery electric light duty vehicles.

The strategy for Efficient Natural Resources outlines how JM's technology leadership in the sector can deliver above market sales growth and improving operating margins from a focus on efficiency.

The programme of increased investment in the Health sector, which began in 2014, continues to build a deeper, broader pipeline of new products based on JM's expertise in active pharmaceutical ingredients. Building scale in this way will drive double digit sales growth and substantial margin expansion in this attractive sector beginning in 2019/20.

In New Markets, JM is focused on battery material technology and has plans to make an initial investment of up to £200 million, starting in 2018, to build capacity to drive growth in a market which could be more than $30 billion sales when battery electric vehicle penetration increases to around 10%.

Guidance is confirmed for the year ending 31st March 2018 and at constant currency with sales growth expected to be c6% with improving operating performance offset by non-cash items. Guidance on foreign exchange is unchanged; it is expected to benefit operating profit by £13 million with estimated restructuring benefits in this financial year unchanged at £10 million.

The group presentation will describe a further £50 million of savings, mainly from procurement, over the three years beginning in financial year 2018/19. Most of the savings will be reinvested with the balance for margin expansion. This is in addition to the £25 million of cost savings announced in June 2017.

Commenting on the capital markets day, Robert MacLeod, Chief Executive, said:

'Johnson Matthey has strong market leading businesses capable of sustained growth and value creation over the short, medium and long term.

'We will enhance our leadership in the high margin, technology driven growth markets we operate in through focused investment and efficiency throughout the group. We are world class chemists. We have the expertise to solve our customers' complex and increasingly challenging problems by scaling up fundamental chemistry to provide commercial solutions which drive our growth.

 'This will create value and a cleaner and healthier world. Through the strategy we will describe at our capital markets day today, we aim to be one of the best performing, most trusted and admired specialty chemical companies in the world.'

Ends

 

Enquiries:

 

Investor Relations

Simon McGough

Sarah Armstrong

Katharine Burrow

 

Head of Investor Relations

Head of Investor Relations

Investor Relations Analyst

 

020 7269 8235

020 7269 8426

020 7269 8444

 

Media

Sally Jones

David Allchurch/Latika Shah

 

 

Director of Corporate Communications

Tulchan Communications

 

 

020 7269 8407

020 7353 4200

www.matthey.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGURABUPMPUU
Date   Source Headline
13th Jul 20215:39 pmRNSHolding(s) in Company
12th Jul 20214:05 pmRNSHolding(s) in Company
9th Jul 20215:01 pmRNSHolding(s) in Company
21st Jun 20213:15 pmRNSHolding(s) in Company
18th Jun 20213:54 pmRNSHolding(s) in Company
17th Jun 20213:56 pmRNSDirector/PDMR Shareholding
15th Jun 20219:00 amRNSAnnual Financial Report
10th Jun 20214:15 pmRNSHolding(s) in Company
27th May 20217:04 amRNSPreliminary results for year ended 31st March 2021
26th May 20217:00 amRNSJohnson Matthey and Plug Power green hydrogen MoU
20th May 202111:34 amRNSDirector/PDMR Shareholding
23rd Apr 20219:51 amRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSStrategic developments in eLNO commercialisation
9th Apr 20214:10 pmRNSHolding(s) in Company
8th Apr 202111:10 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading update and strategic review of Health
24th Mar 202111:14 amRNSHolding(s) in Company
19th Mar 20213:00 pmRNSHolding(s) in Company
18th Mar 202111:53 amRNSDirector/PDMR Shareholding
9th Mar 20214:40 pmRNSHolding(s) in Company
8th Mar 202112:20 pmRNSHolding(s) in Company
24th Feb 20214:17 pmRNSDirector/PDMR Shareholding
18th Feb 20213:45 pmRNSDirector/PDMR Shareholding
16th Feb 20219:15 amRNSHolding(s) in Company
12th Feb 202110:15 amRNSHolding(s) in Company
8th Feb 20212:14 pmRNSDirector/PDMR Shareholding
8th Feb 20212:02 pmRNSDirector/PDMR Shareholding
22nd Jan 20214:15 pmRNSHolding(s) in Company
22nd Jan 202110:31 amRNSDirector/PDMR Shareholding
12th Jan 20217:00 amRNSAppointment of Chief Financial Officer
18th Dec 20203:29 pmRNSDirector/PDMR Shareholding
20th Nov 20202:55 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSJohnson Matthey half year results 30 Sept 2020
13th Nov 20204:45 pmRNSHolding(s) in Company
22nd Oct 20204:49 pmRNSDirector/PDMR Shareholding
29th Sep 20204:52 pmRNSDirector/PDMR Shareholding
21st Sep 20204:08 pmRNSDirector/PDMR Shareholding
18th Sep 20204:21 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSJohnson Matthey: Hydrogen Seminar
21st Aug 20209:05 amRNSDirector/PDMR Shareholding
11th Aug 202010:12 amRNSDoug Webb - New Directorship
6th Aug 20204:19 pmRNSDirector/PDMR Shareholding
6th Aug 20204:11 pmRNSDirector/PDMR Shareholding
5th Aug 20204:25 pmRNSDirector/PDMR Shareholding
5th Aug 20204:21 pmRNSDirector/PDMR Shareholding
5th Aug 20204:04 pmRNSDirector/PDMR Shareholding
30th Jul 20202:45 pmRNSDirector Declaration
23rd Jul 20203:25 pmRNSResult of AGM
23rd Jul 20207:00 amRNSJohnson Matthey Q1 AGM trading update
17th Jul 20201:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.